LivaNova PLC Ordinary Shares (LIVN)

Price$73.81

Value ScoreC

Growth ScoreC

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)22.22%

Price vs S&P 500 (4W)16.01%

VGM Score57.00

Market Capitalization$4.06B

P/E Ratio (Annual)61.31x

All Metrics

P/CF (Annual)15.97x

Book Value / Share (Quarterly)$22.06

P/TBV (Annual)3.46x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)10.75%

Cash Flow / Share (Quarterly)$2.93

Price vs S&P 500 (YTD)9.01%

Gross Margin (TTM)67.48%

Net Profit Margin (TTM)7.47%

EPS (TTM)$1.95

10-Day Avg Trading Volume0.66M

EPS Excl Extra (TTM)$1.95

Revenue Growth (5Y)8.24%

EPS (Annual)$-4.45

ROI (Annual)-15.38%

Gross Margin (Annual)67.71%

Net Profit Margin (5Y Avg)-6.49%

Cash / Share (Quarterly)$9.83

P/E Basic Excl Extra (TTM)37.90x

Revenue Growth QoQ (YoY)14.33%

P/E Normalized (Annual)61.31x

ROA (Last FY)-9.30%

Revenue Growth TTM (YoY)12.40%

EBITD / Share (TTM)$3.95

ROE (5Y Avg)-6.34%

Operating Margin (TTM)13.07%

Cash Flow / Share (Annual)$3.17

P/B Ratio3.35x

P/B Ratio (Quarterly)2.87x

Net Income / Employee (Annual)$-73,500

EV / Revenue (TTM)2.66x

Net Interest Coverage (TTM)-2.97x

ROA (TTM)4.21%

EPS Growth QoQ (YoY)-44.41%

EV / EBITDA (TTM)17.49x

EPS Incl Extra (Annual)$-4.45

Current Ratio (Annual)1.36x

Quick Ratio (Quarterly)1.01x

3-Month Avg Trading Volume0.82M

52-Week Price Return70.95%

EV / Free Cash Flow (Annual)21.98x

P/E Incl Extra (TTM)37.90x

Revenue / Employee (TTM)$434,400

Tangible BV / Share (Quarterly)$17.97

P/S Ratio (Annual)2.93x

Asset Turnover (Annual)0.53x

52-Week High$75.81

Operating Margin (5Y Avg)0.51%

EPS Excl Extra (Annual)$-4.45

CapEx CAGR (5Y)18.27%

Tangible BV CAGR (5Y)7.63%

26-Week Price Return38.15%

Quick Ratio (Annual)1.05x

13-Week Price Return3.94%

Total Debt / Equity (Annual)0.31x

Current Ratio (Quarterly)1.33x

Enterprise Value$3.81B

Revenue / Share Growth (5Y)5.77%

Asset Turnover (TTM)0.56x

Book Value / Share Growth (5Y)-0.75%

Revenue / Employee (Annual)$420,600

Inventory Turnover (Annual)2.87x

Pretax Margin (Annual)-15.91%

Cash / Share (Annual)$11.63

3-Month Return Std Dev46.20%

Gross Margin (5Y Avg)68.29%

Net Income / Employee (TTM)$32,500

EBITDA Interim CAGR (5Y)163.76%

ROE (Last FY)-20.21%

Net Interest Coverage (Annual)2.89x

EPS Basic Excl Extra (Annual)$-4.45

P/FCF (TTM)25.22x

Receivables Turnover (TTM)6.65x

EV / Free Cash Flow (TTM)23.65x

Total Debt / Equity (Quarterly)0.24x

EPS Incl Extra (TTM)$1.95

Receivables Turnover (Annual)6.79x

ROI (TTM)6.89%

P/S Ratio (TTM)2.83x

Pretax Margin (5Y Avg)-7.05%

Revenue / Share (Annual)$25.45

Tangible BV / Share (Annual)$17.75

Forward P/E16.84x

Price vs S&P 500 (52W)42.75%

P/E Ratio (TTM)37.90x

Year-to-Date Return19.94%

5-Day Price Return-0.04%

EPS Normalized (Annual)$-4.45

ROA (5Y Avg)-3.20%

Net Profit Margin (Annual)-17.47%

Month-to-Date Return22.80%

Cash Flow / Share (TTM)$0.98

EBITD / Share (Annual)$4.11

Operating Margin (Annual)14.09%

LT Debt / Equity (Annual)0.29x

P/CF (TTM)16.54x

ROI (5Y Avg)-4.99%

P/E Excl Extra (TTM)37.90x

LT Debt / Equity (Quarterly)0.24x

EPS Basic Excl Extra (TTM)$1.95

P/TBV (Quarterly)3.52x

P/B Ratio (Annual)2.80x

Inventory Turnover (TTM)2.92x

Pretax Margin (TTM)8.54%

Book Value / Share (Annual)$21.96

Price vs S&P 500 (13W)-5.80%

Beta0.89x

P/FCF (Annual)23.44x

Revenue / Share (TTM)$25.62

ROE (TTM)9.14%

52-Week Low$41.02

vGradeC

gGradeC

mGradeB

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.98est. 0.91

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.12

Industry Peers — Electromedical Equipment(31)

Symbol	Value Score	Growth Score	Momentum Score	Price
LIVNLivaNova PLC Ordinary Shares	C	C	B	$73.81
MDTMedtronic plc	B	D	D	$73.98
MASIMasimo Corporation	D	D	B	$178.59
ITGRInteger Holdings Corporation	B	C	C	$90.16
TMDXTransMedics Group, Inc. Common Stock	C	B	F	$67.53
AXGNAxogen, Inc. Common Stock	F	B	B	$38.72
BLFSBioLife Solutions Inc.	F	B	B	$26.63
CNMDCONMED Corporation	A	C	D	$34.65
INMDInMode Ltd. Ordinary Shares	A	D	C	$13.59
CBLLCeriBell, Inc. Common Stock	D	A	C	$17.61
CVCapsoVision, Inc. Common Stock	F	D	B	$6.90

About

LivaNova is a UK-based medical-device company specializing in cardiopulmonary and neuromodulation solutions. Its portfolio includes heart-lung machines and oxygenation equipment for cardiac and respiratory support, as well as neuromodulation devices for treatment-resistant epilepsy and depression. The company generates approximately 50% of revenue from the US market, 21% from Europe, and the remainder from other regions.